ACE and glioma: In another study, Lian et al. suggested the insertion/deletion (I/D) genetic variant of the ACE gene as a risk biomarker for glioma, and performed a case-control study in a Chinese population, which showed that glioma patients had a significantly higher prevalence of the ACE DD-genotype detected in blood [51].